PROXY STATEMENT

Company

Pasithea Therapeutics Corp.

Filed

October 26, 2023

Period of Report

November 29, 2023

Accession Number

0001013762-23-006985

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →